Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 47

1.

Impact of Serum Cystatin C-Based Glomerular Filtration Rate Estimates on Drug Dose Selection in Hospitalized Patients.

Peters BJ, Rule AD, Kashani KB, Lieske JC, Mara KC, Dierkhising RA, Barreto EF.

Pharmacotherapy. 2018 Oct;38(10):1068-1073. doi: 10.1002/phar.2175. Epub 2018 Sep 12.

PMID:
30120844
2.

Structure Dependence of Pyridine and Benzene Derivatives on Interactions with Model Membranes.

Peters BJ, Van Cleave C, Haase AA, Hough JPB, Giffen-Kent KA, Cardiff GM, Sostarecz AG, Crick DC, Crans DC.

Langmuir. 2018 Jul 31;34(30):8939-8951. doi: 10.1021/acs.langmuir.8b01661. Epub 2018 Jul 19.

3.

Hadean silicate differentiation preserved by anomalous 142Nd/144Nd ratios in the Réunion hotspot source.

Peters BJ, Carlson RW, Day JMD, Horan MF.

Nature. 2018 Feb 28;555(7694):89-93. doi: 10.1038/nature25754.

PMID:
29493592
4.

Utilization of Molecular Testing and Survival Outcomes of Treatment with First- or Second-line Tyrosine Kinase Inhibitors in Advanced Non-small Cell Lung Cancer in a Dutch Population.

Sluga R, VAN DEN Borne BEEM, Roepman P, Peters BJM, Kastelijn EA, Schramel FMNH.

Anticancer Res. 2018 Jan;38(1):393-400.

PMID:
29277800
5.

Cardiovascular indexes of threat impair responsiveness in situations of conflicting interests.

Peters BJ, Reis HT, Jamieson JP.

Int J Psychophysiol. 2018 Jan;123:1-7. doi: 10.1016/j.ijpsycho.2017.12.005. Epub 2017 Dec 15.

PMID:
29253512
6.

A Synthetic Isoprenoid Lipoquinone, Menaquinone-2, Adopts a Folded Conformation in Solution and at a Model Membrane Interface.

Koehn JT, Magallanes ES, Peters BJ, Beuning CN, Haase AA, Zhu MJ, Rithner CD, Crick DC, Crans DC.

J Org Chem. 2018 Jan 5;83(1):275-288. doi: 10.1021/acs.joc.7b02649. Epub 2017 Dec 12.

PMID:
29168636
7.

Trends in prescribing systemic treatment and overall survival for non-small cell lung cancer stage IIIB/IV in the Netherlands: 2008-2012.

Peters BJM, Cramer-Vd Welle CM, Smit AAJ, Schramel FMNH, van de Garde EMW; Santeon NSCLC Study Group.

Cancer Epidemiol. 2017 Dec;51:1-6. doi: 10.1016/j.canep.2017.08.001. Epub 2017 Sep 28.

8.
9.

The consequences of having a dominant romantic partner on testosterone responses during a social interaction.

Peters BJ, Hammond MD, Reis HT, Jamieson JP.

Psychoneuroendocrinology. 2016 Dec;74:308-315. doi: 10.1016/j.psyneuen.2016.09.024. Epub 2016 Sep 29.

PMID:
27701045
10.

Differences in Interactions of Benzoic Acid and Benzoate with Interfaces.

Peters BJ, Groninger AS, Fontes FL, Crick DC, Crans DC.

Langmuir. 2016 Sep 20;32(37):9451-9. doi: 10.1021/acs.langmuir.6b02073. Epub 2016 Sep 8.

11.

Quantitative and qualitative assessment of real world data comparative effectiveness research of systemic therapies in lung oncology: A systematic review.

Peters BJM, Janssen VEMT, Schramel FM, van de Garde EMW.

Cancer Epidemiol. 2016 Oct;44:5-15. doi: 10.1016/j.canep.2016.07.005. Epub 2016 Jul 21. Review.

PMID:
27449577
12.

The consequences of suppressing affective displays in romantic relationships: A challenge and threat perspective.

Peters BJ, Jamieson JP.

Emotion. 2016 Oct;16(7):1050-66. doi: 10.1037/emo0000202. Epub 2016 Jun 27.

PMID:
27348498
13.

Physiological and cognitive consequences of suppressing and expressing emotion in dyadic interactions.

Peters BJ, Overall NC, Jamieson JP.

Int J Psychophysiol. 2014 Oct;94(1):100-7. doi: 10.1016/j.ijpsycho.2014.07.015. Epub 2014 Aug 7.

PMID:
25109434
14.

Rethinking butterflies: the affective, physiological, and performance effects of reappraising arousal during social evaluation.

Beltzer ML, Nock MK, Peters BJ, Jamieson JP.

Emotion. 2014 Aug;14(4):761-8. doi: 10.1037/a0036326. Epub 2014 Apr 21.

PMID:
24749642
15.

The SLCO1B1 c.521T>C polymorphism is associated with dose decrease or switching during statin therapy in the Rotterdam Study.

de Keyser CE, Peters BJ, Becker ML, Visser LE, Uitterlinden AG, Klungel OH, Verstuyft C, Hofman A, Maitland-van der Zee AH, Stricker BH.

Pharmacogenet Genomics. 2014 Jan;24(1):43-51. doi: 10.1097/FPC.0000000000000018.

PMID:
24263182
16.

Validation of an automated method for compounding monoclonal antibody patient doses: case studies of Avastin (bevacizumab), Remicade (infliximab) and Herceptin (trastuzumab).

Peters BJ, Capelle MA, Arvinte T, van de Garde EM.

MAbs. 2013 Jan-Feb;5(1):162-70. doi: 10.4161/mabs.22873. Epub 2012 Dec 19.

17.

Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study.

Voight BF, Peloso GM, Orho-Melander M, Frikke-Schmidt R, Barbalic M, Jensen MK, Hindy G, Hólm H, Ding EL, Johnson T, Schunkert H, Samani NJ, Clarke R, Hopewell JC, Thompson JF, Li M, Thorleifsson G, Newton-Cheh C, Musunuru K, Pirruccello JP, Saleheen D, Chen L, Stewart A, Schillert A, Thorsteinsdottir U, Thorgeirsson G, Anand S, Engert JC, Morgan T, Spertus J, Stoll M, Berger K, Martinelli N, Girelli D, McKeown PP, Patterson CC, Epstein SE, Devaney J, Burnett MS, Mooser V, Ripatti S, Surakka I, Nieminen MS, Sinisalo J, Lokki ML, Perola M, Havulinna A, de Faire U, Gigante B, Ingelsson E, Zeller T, Wild P, de Bakker PI, Klungel OH, Maitland-van der Zee AH, Peters BJ, de Boer A, Grobbee DE, Kamphuisen PW, Deneer VH, Elbers CC, Onland-Moret NC, Hofker MH, Wijmenga C, Verschuren WM, Boer JM, van der Schouw YT, Rasheed A, Frossard P, Demissie S, Willer C, Do R, Ordovas JM, Abecasis GR, Boehnke M, Mohlke KL, Daly MJ, Guiducci C, Burtt NP, Surti A, Gonzalez E, Purcell S, Gabriel S, Marrugat J, Peden J, Erdmann J, Diemert P, Willenborg C, König IR, Fischer M, Hengstenberg C, Ziegler A, Buysschaert I, Lambrechts D, Van de Werf F, Fox KA, El Mokhtari NE, Rubin D, Schrezenmeir J, Schreiber S, Schäfer A, Danesh J, Blankenberg S, Roberts R, McPherson R, Watkins H, Hall AS, Overvad K, Rimm E, Boerwinkle E, Tybjaerg-Hansen A, Cupples LA, Reilly MP, Melander O, Mannucci PM, Ardissino D, Siscovick D, Elosua R, Stefansson K, O'Donnell CJ, Salomaa V, Rader DJ, Peltonen L, Schwartz SM, Altshuler D, Kathiresan S.

Lancet. 2012 Aug 11;380(9841):572-80. doi: 10.1016/S0140-6736(12)60312-2. Epub 2012 May 17. Erratum in: Lancet. 2012 Aug 11;380(9841):564.

18.

Genetic variability within the cholesterol lowering pathway and the effectiveness of statins in reducing the risk of MI.

Peters BJ, Pett H, Klungel OH, Stricker BH, Psaty BM, Glazer NL, Wiggins KL, Bis JC, de Boer A, Maitland-van der Zee AH.

Atherosclerosis. 2011 Aug;217(2):458-64. doi: 10.1016/j.atherosclerosis.2011.06.023. Epub 2011 Jun 17.

19.

CYP2C19 and ABCB1 genes and individualized treatment with clopidogrel.

Peters BJ, Harmsze AM, ten Berg JM, Maitland-van der Zee AH, Tjoeng MM, de Boer A, Deneer VH.

Pharmacogenomics. 2011 Feb;12(2):141-4. doi: 10.2217/pgs.10.211. No abstract available.

PMID:
21332306
20.

Meta-analysis of Dense Genecentric Association Studies Reveals Common and Uncommon Variants Associated with Height.

Lanktree MB, Guo Y, Murtaza M, Glessner JT, Bailey SD, Onland-Moret NC, Lettre G, Ongen H, Rajagopalan R, Johnson T, Shen H, Nelson CP, Klopp N, Baumert J, Padmanabhan S, Pankratz N, Pankow JS, Shah S, Taylor K, Barnard J, Peters BJ, Maloney CM, Lobmeyer MT, Stanton A, Zafarmand MH, Romaine SP, Mehta A, van Iperen EP, Gong Y, Price TS, Smith EN, Kim CE, Li YR, Asselbergs FW, Atwood LD, Bailey KM, Bhatt D, Bauer F, Behr ER, Bhangale T, Boer JM, Boehm BO, Bradfield JP, Brown M, Braund PS, Burton PR, Carty C, Chandrupatla HR, Chen W, Connell J, Dalgeorgou C, Boer Ad, Drenos F, Elbers CC, Fang JC, Fox CS, Frackelton EC, Fuchs B, Furlong CE, Gibson Q, Gieger C, Goel A, Grobbee DE, Hastie C, Howard PJ, Huang GH, Johnson WC, Li Q, Kleber ME, Klein BE, Klein R, Kooperberg C, Ky B, Lacroix A, Lanken P, Lathrop M, Li M, Marshall V, Melander O, Mentch FD, Meyer NJ, Monda KL, Montpetit A, Murugesan G, Nakayama K, Nondahl D, Onipinla A, Rafelt S, Newhouse SJ, Otieno FG, Patel SR, Putt ME, Rodriguez S, Safa RN, Sawyer DB, Schreiner PJ, Simpson C, Sivapalaratnam S, Srinivasan SR, Suver C, Swergold G, Sweitzer NK, Thomas KA, Thorand B, Timpson NJ, Tischfield S, Tobin M, Tomaszewski M, Verschuren WM, Wallace C, Winkelmann B, Zhang H, Zheng D, Zhang L, Zmuda JM, Clarke R, Balmforth AJ, Danesh J, Day IN, Schork NJ, de Bakker PI, Delles C, Duggan D, Hingorani AD, Hirschhorn JN, Hofker MH, Humphries SE, Kivimaki M, Lawlor DA, Kottke-Marchant K, Mega JL, Mitchell BD, Morrow DA, Palmen J, Redline S, Shields DC, Shuldiner AR, Sleiman PM, Smith GD, Farrall M, Jamshidi Y, Christiani DC, Casas JP, Hall AS, Doevendans PA, Christie JD, Berenson GS, Murray SS, Illig T, Dorn GW 2nd, Cappola TP, Boerwinkle E, Sever P, Rader DJ, Reilly MP, Caulfield M, Talmud PJ, Topol E, Engert JC, Wang K, Dominiczak A, Hamsten A, Curtis SP, Silverstein RL, Lange LA, Sabatine MS, Trip M, Saleheen D, Peden JF, Cruickshanks KJ, März W, O'Connell JR, Klungel OH, Wijmenga C, Maitland-van der Zee AH, Schadt EE, Johnson JA, Jarvik GP, Papanicolaou GJ; Hugh Watkins on behalf of PROCARDIS, Grant SF, Munroe PB, North KE, Samani NJ, Koenig W, Gaunt TR, Anand SS, van der Schouw YT; Meena Kumari on behalf of the Whitehall II Study and the WHII 50K Group, Soranzo N, Fitzgerald GA, Reiner A, Hegele RA, Hakonarson H, Keating BJ.

Am J Hum Genet. 2011 Jan 7;88(1):6-18. doi: 10.1016/j.ajhg.2010.11.007. Epub 2010 Dec 30. Erratum in: Am J Hum Genet. 2012 Jun 8;90(6):1117. Tomaszweski, Maciej [corrected to Tomaszewski, Maciej].

Supplemental Content

Support Center